Persantine: Variation in Response Trial

NCT00763009 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Limited numbers of patients qualified for trial

Conditions

Coronary Artery Disease

Interventions

DRUG: dipyridamole

Sponsor

UConn Health

Collaborators

[object Object]